Euronext
Note: This is a daily stock update and the information stands true as of 07/11/25, 09:00 CET.
Company Update:
Our analyst is keen to buy the share at this level. He sees Euronext as offering an attractive risk profile here. The optionality on Athex is a positive and any rise in volatility on European equity would also be more favorable for the stock. Last but not least, valuation is now back to much more palatable levels with PE back below the 20x mark. Note also that Euronext may benefit from the issues of Deutsche Börse, which is entangled in an investigation by the EU antitrust authority regarding a possible collusion issue with the Nasdaq Stock Exchange.
For daily updates, subscribe to our newsletter and for detailed information, reach out to us at sales@alphavalue.eu
Company Update:
Revenue was a1% miss ( up11%) but EBITDA grew 13%, 2% better than expected, with strong cost discipline.
Euronext upgraded its costs guidance for 2025, seeing underlying opex excluding D&A at €660m vs €670m while it launched a new €250m buyback program starting on 18 November 2025
Results on the Athex bid will be announced on 19 November 2025. Should the takeover occur, ENX has guided for €12m of annual cash synergies from year 3 post-merger.
Expert Opinion: Our analyst is keen to buy the share at this level. He sees Euronext as offering an attractive risk profile here. The optionality on Athex is a positive and any rise in volatility on European equity would also be more favorable for the stock. Last but not least, valuation is now back to much more palatable levels with PE back below the 20x mark. Note also that Euronext may benefit from the issues of Deutsche Börse, which is entangled in an investigation by the EU antitrust authority regarding a possible collusion issue with the Nasdaq Stock Exchange.
For daily updates, subscribe to our newsletter and for detailed information, reach out to us at sales@alphavalue.eu
Subscribe to our blog
